Rare and localized events stabilize microbial community composition and patterns of spatial self-organization in a fluctuating environment.
Ciccarese D
ISME J. 2022 Jan 25;16(5):1453-1463. doi: 10.1038/s41396-022-01189-9
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
Malcovati L
Blood. 2013 Aug 26;122(17):2943-64. doi: 10.1182/blood-2013-03-492884
Clinical and biological implications of driver mutations in myelodysplastic syndromes.
Papaemmanuil E
Blood. 2013 Sep 12;122(22):3616-27; quiz 3699. doi: 10.1182/blood-2013-08-518886
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.
Della Porta MG
Blood. 2014 Feb 20;123(15):2333-42. doi: 10.1182/blood-2013-12-542720
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.
Della Porta MG
Leukemia. 2014 May 20;29(1):66-75. doi: 10.1038/leu.2014.161
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM).
Della Porta MG
Leukemia. 2015 Feb 27;29(7):1502-13. doi: 10.1038/leu.2015.55
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.
Della Porta MG
J Clin Oncol. 34(30):3627-3637. doi: 10.1200/JCO.2016.67.3616
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.
Della Porta MG
Leukemia. 2017 Mar 21;31(11):2449-2457. doi: 10.1038/leu.2017.88
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Passamonti F
Lancet Haematol. 2020 Aug 13;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
Bernard E
Nat Med. 2020 Aug 3;26(10):1549-1556. doi: 10.1038/s41591-020-1008-z